Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine

Da Hong Wang, Yuka Funamori, Satoru Ikeda, Masaki Sato, Shohei Kira, Kazuhisa Taketa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis was compared between C3H/AnLC(s)/(b)C(s)/(b) (acatalasemic) and C3H/AnLC(s)/(a)C(s)/(a) (normal) mice. A total of 31 normal and 38 acatalasemic male mice, average age 9 weeks, received a single intraperitoneal injection of DEN (75 mg/kg body wt) weekly for 6 weeks. All animals that survived until the end of week 31 (25th week after the last injection of DEN)were sacrificed and the development of liver tumors was found. They grossly varied from one to multiple in number and from i to 15 mm in diameter in both groups. The numbers and size of liver tumors per liver were significantly greater (P <0.05) in acatalasemic mice (mean ± S.D.: 3.8 ± 2.0 in number per liver; 9.6 ± 7.4 in mm diameter per liver) than in normal mice (1.8 ± 1.1 in number per liver; 2.8 ± 1.9 in mm diameter per liver). Histological examination of the tumor tissues revealed the development of well-differentiated hepatocellular carcinomas. We suggest that H2O2 or ·OH formed from H2O2 is likely to be involved in DEN-induced hepatocarcinogenesis and catalase plays a critical role in the prevention of hepatocarcinogenesis.

Original languageEnglish
Pages (from-to)217-224
Number of pages8
JournalHepatology Research
Volume12
Issue number3
Publication statusPublished - Oct 1998

Fingerprint

Diethylnitrosamine
Liver
Neoplasms
Intraperitoneal Injections
Catalase
Hepatocellular Carcinoma
Carcinogenesis
Injections

Keywords

  • Acatalasemic mice
  • Catalase
  • Diethylnitrosamine (DEN)
  • Hepatocarcinogenesis
  • Hydrogen peroxide
  • Hydroxyl radical

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Wang, D. H., Funamori, Y., Ikeda, S., Sato, M., Kira, S., & Taketa, K. (1998). Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. Hepatology Research, 12(3), 217-224.

Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. / Wang, Da Hong; Funamori, Yuka; Ikeda, Satoru; Sato, Masaki; Kira, Shohei; Taketa, Kazuhisa.

In: Hepatology Research, Vol. 12, No. 3, 10.1998, p. 217-224.

Research output: Contribution to journalArticle

Wang, DH, Funamori, Y, Ikeda, S, Sato, M, Kira, S & Taketa, K 1998, 'Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine', Hepatology Research, vol. 12, no. 3, pp. 217-224.
Wang DH, Funamori Y, Ikeda S, Sato M, Kira S, Taketa K. Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. Hepatology Research. 1998 Oct;12(3):217-224.
Wang, Da Hong ; Funamori, Yuka ; Ikeda, Satoru ; Sato, Masaki ; Kira, Shohei ; Taketa, Kazuhisa. / Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. In: Hepatology Research. 1998 ; Vol. 12, No. 3. pp. 217-224.
@article{7b7b476e0e3a4aab85b7533e06d3d384,
title = "Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine",
abstract = "Diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis was compared between C3H/AnLC(s)/(b)C(s)/(b) (acatalasemic) and C3H/AnLC(s)/(a)C(s)/(a) (normal) mice. A total of 31 normal and 38 acatalasemic male mice, average age 9 weeks, received a single intraperitoneal injection of DEN (75 mg/kg body wt) weekly for 6 weeks. All animals that survived until the end of week 31 (25th week after the last injection of DEN)were sacrificed and the development of liver tumors was found. They grossly varied from one to multiple in number and from i to 15 mm in diameter in both groups. The numbers and size of liver tumors per liver were significantly greater (P <0.05) in acatalasemic mice (mean ± S.D.: 3.8 ± 2.0 in number per liver; 9.6 ± 7.4 in mm diameter per liver) than in normal mice (1.8 ± 1.1 in number per liver; 2.8 ± 1.9 in mm diameter per liver). Histological examination of the tumor tissues revealed the development of well-differentiated hepatocellular carcinomas. We suggest that H2O2 or ·OH formed from H2O2 is likely to be involved in DEN-induced hepatocarcinogenesis and catalase plays a critical role in the prevention of hepatocarcinogenesis.",
keywords = "Acatalasemic mice, Catalase, Diethylnitrosamine (DEN), Hepatocarcinogenesis, Hydrogen peroxide, Hydroxyl radical",
author = "Wang, {Da Hong} and Yuka Funamori and Satoru Ikeda and Masaki Sato and Shohei Kira and Kazuhisa Taketa",
year = "1998",
month = "10",
language = "English",
volume = "12",
pages = "217--224",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine

AU - Wang, Da Hong

AU - Funamori, Yuka

AU - Ikeda, Satoru

AU - Sato, Masaki

AU - Kira, Shohei

AU - Taketa, Kazuhisa

PY - 1998/10

Y1 - 1998/10

N2 - Diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis was compared between C3H/AnLC(s)/(b)C(s)/(b) (acatalasemic) and C3H/AnLC(s)/(a)C(s)/(a) (normal) mice. A total of 31 normal and 38 acatalasemic male mice, average age 9 weeks, received a single intraperitoneal injection of DEN (75 mg/kg body wt) weekly for 6 weeks. All animals that survived until the end of week 31 (25th week after the last injection of DEN)were sacrificed and the development of liver tumors was found. They grossly varied from one to multiple in number and from i to 15 mm in diameter in both groups. The numbers and size of liver tumors per liver were significantly greater (P <0.05) in acatalasemic mice (mean ± S.D.: 3.8 ± 2.0 in number per liver; 9.6 ± 7.4 in mm diameter per liver) than in normal mice (1.8 ± 1.1 in number per liver; 2.8 ± 1.9 in mm diameter per liver). Histological examination of the tumor tissues revealed the development of well-differentiated hepatocellular carcinomas. We suggest that H2O2 or ·OH formed from H2O2 is likely to be involved in DEN-induced hepatocarcinogenesis and catalase plays a critical role in the prevention of hepatocarcinogenesis.

AB - Diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis was compared between C3H/AnLC(s)/(b)C(s)/(b) (acatalasemic) and C3H/AnLC(s)/(a)C(s)/(a) (normal) mice. A total of 31 normal and 38 acatalasemic male mice, average age 9 weeks, received a single intraperitoneal injection of DEN (75 mg/kg body wt) weekly for 6 weeks. All animals that survived until the end of week 31 (25th week after the last injection of DEN)were sacrificed and the development of liver tumors was found. They grossly varied from one to multiple in number and from i to 15 mm in diameter in both groups. The numbers and size of liver tumors per liver were significantly greater (P <0.05) in acatalasemic mice (mean ± S.D.: 3.8 ± 2.0 in number per liver; 9.6 ± 7.4 in mm diameter per liver) than in normal mice (1.8 ± 1.1 in number per liver; 2.8 ± 1.9 in mm diameter per liver). Histological examination of the tumor tissues revealed the development of well-differentiated hepatocellular carcinomas. We suggest that H2O2 or ·OH formed from H2O2 is likely to be involved in DEN-induced hepatocarcinogenesis and catalase plays a critical role in the prevention of hepatocarcinogenesis.

KW - Acatalasemic mice

KW - Catalase

KW - Diethylnitrosamine (DEN)

KW - Hepatocarcinogenesis

KW - Hydrogen peroxide

KW - Hydroxyl radical

UR - http://www.scopus.com/inward/record.url?scp=0031679526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031679526&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 217

EP - 224

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 3

ER -